Impact on Risk Stratification of Overlap Syndrome Phenotype in Patients With E1784K Mutation in SCN5A
N/A
In patients expressing the SCN5A-E1784K mutation (Glu1784Lys), cardiovascul...
Status
Completed
Location
CHU de La Réunion
Start Date
2022-04-05
Trial ID
NCT05274646
A Pilot Feasibility Study of Oral 5-Fluorocytosine and Genetically-Modified Neural Stem Cells Expressing E.Coli Cytosine Deaminase for Treatment of Recurrent High Grade Gliomas
PHASE1
RATIONALE: Genetically-modified neural stem cells (NSCs) that convert 5-flu...